Clinical Trials
9
Active:6
Completed:1
Trial Phases
3 Phases
Phase 1:6
Phase 3:1
Not Applicable:2
Drug Approvals
2
SFDA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (66.7%)Not Applicable
2 (22.2%)Phase 3
1 (11.1%)Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865379
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865457
Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis
Phase 3
Completed
- Conditions
- OsteoarthritisOsteoarthritis, Knee
- Interventions
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 380
- Registration Number
- NCT02688400
- Locations
- 🇦🇹
State Hospital Stockerau Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria
🇧🇪Institut Médical Spécialisé - Centre DISCCA, Hornu, Belgium
🇧🇪Reumatologie Medizorg Merksem, Merksem, Belgium
News
No news found